Anna M. Bofin
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Cancer, Hypoxia, and Metabolism
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
-
- Breast Cancer Treatment Studies 19
- Cancer Genomics and Diagnostics 7
- Oncology 31
- HER2/EGFR in Cancer Research 11
- Global Cancer Incidence and Screening 7
- Co-authors
- Signe OpdahlMonica Jernberg EngstrømBorgny YtterhusTone F. BathenSteinar LundgrenB HagmarOlav A. HaugenLars J. Vatten
- Journals
- Breast Cancer Research and Treatment (9 papers)Journal of Clinical Pathology (6 papers)BMC Cancer (5 papers)Cytopathology (4 papers)Histopathology (3 papers)
- Partner nations
- NorwayUnited KingdomUnited States
In The Last Decade
Anna M. Bofin
68 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 138
- Cancer Research 661
- Oncology 618
- Radiology, Nuclear Medicine and Imaging 343
- Molecular Biology 689
- Pathology and Forensic Medicine 174
Countries citing papers authored by Anna M. Bofin
This map shows the geographic impact of Anna M. Bofin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna M. Bofin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna M. Bofin more than expected).
Fields of papers citing papers by Anna M. Bofin
This network shows the impact of papers produced by Anna M. Bofin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna M. Bofin. The network helps show where Anna M. Bofin may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna M. Bofin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 3 | |
| 3 | 2023 | 2 | |
| 4 | 2022 | 3 | |
| 5 | 2021 | 12 | |
| 6 | 2021 | 7 | |
| 7 | 2021 | 5 | |
| 8 | 2019 | 9 | |
| 9 | 2018 | 28 | |
| 10 | 2017 | 11 | |
| 11 | 2015 | 20 | |
| 12 | 2014 | 18 | |
| 13 | 2014 | 23 | |
| 14 | 2012 | 71 | |
| 15 | 2011 | 27 | |
| 16 | 2008 | 128 | |
| 17 | 2007 | 17 | |
| 18 | 2004 | 24 | |
| 19 | 2004 | 8 | |
| 20 | 2003 | 42 |
About Anna M. Bofin
Anna M. Bofin is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Family Practice, having authored 70 papers that have together received 1.7k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (19 papers), Breast Lesions and Carcinomas (15 papers), HER2/EGFR in Cancer Research (11 papers), MRI in cancer diagnosis (10 papers), Cancer Genomics and Diagnostics (7 papers), Global Cancer Incidence and Screening (7 papers), Advanced MRI Techniques and Applications (7 papers) and Metabolomics and Mass Spectrometry Studies (5 papers). The work is most often cited by research in Cancer Research (661 citations), Oncology (618 citations), Radiology, Nuclear Medicine and Imaging (343 citations), Molecular Biology (689 citations) and Pathology and Forensic Medicine (174 citations). Anna M. Bofin has collaborated with scholars based in Norway, United Kingdom and United States. Frequent co-authors include Signe Opdahl, Monica Jernberg Engstrøm, Borgny Ytterhus, Tone F. Bathen, Steinar Lundgren, B Hagmar, Olav A. Haugen, Lars J. Vatten, David W. Hosmer and Morten Wang Fagerland. Their work appears in journals such as Breast Cancer Research and Treatment, Journal of Clinical Pathology, BMC Cancer, Cytopathology and Histopathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.